Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated With Percutaneous Coronary Intervention
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3150 participants.
Also called NCT06692140
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 3,150 participants
- Sponsor
- Registry
-
NCT06692140
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT06692140. Randomized; single masking; primary purpose treatment. Start 2024-11-16 (actual); primary completion 2028-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated With Percutaneous Coronary Intervention
- Acronym
- SORT OUT XII
- Condition
- Ischemia, Myocardial
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s)
- Intervention (Device)
- PCI with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s))
- Lead sponsor
- Odense University Hospital
Record details
- Record id
cardio:ct-nct06692140- Content hash
e2a0ab733a17b6eaa3339b1b523bbd51a5cbeaccb2dc125428869290541decdc